1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Parnax Lab Limited

Parnax Lab Limited

PARNAXLAB.BO
Parnax Lab LimitedIN flagBombay Stock Exchange
145.95
INR
-0.40
- -
1.68BMarket Cap

Total Valuation

Parnax Lab Limited carries a market capitalization of 1.68B, placing it among publicly traded companies globally. Its enterprise value stands at 2.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.68B
Enterprise Value2.28B

Share Statistics

Parnax Lab Limited currently has 11.49M shares outstanding.

Shares Outstanding11.49M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Parnax Lab Limited trades at a trailing price-to-earnings ratio of 12.51. The price-to-sales ratio is 0.59, and the price-to-book ratio stands at 12.84.

PE Ratio12.51
PS Ratio0.59
PB Ratio12.84
P/TBV Ratio1.56
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Parnax Lab Limited trades at an EV/EBITDA multiple of 11.88 and an EV/FCF ratio of 53.89. The EV/Sales ratio of 0.92 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.88 provides insight into valuation relative to core operating earnings.

EV / Sales0.92
EV / EBITDA11.88
EV / EBIT11.88
EV / FCF53.89

Financial Position

Parnax Lab Limited maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 86.87, indicating elevated leverage, while an interest coverage ratio of 3.36 demonstrates adequate ability to service its debt obligations.

Current Ratio0.97
Quick Ratio0.02
Debt / Equity86.87
Debt / EBITDA4.31
Interest Coverage3.36

Financial Efficiency

Parnax Lab Limited posts a return on equity of 30.08 and a return on invested capital of 8.71.

Return on Equity (ROE)30.08
Return on Assets (ROA)5.65
Return on Invested Capital (ROIC)8.71
Return on Capital Employed (ROCE)13.87
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.75

Taxes

Over the trailing twelve months, Parnax Lab Limited has paid 41.08M in income taxes, reflecting an effective tax rate of 25.83.

Income Tax41.08M
Effective Tax Rate25.83

Stock Price Statistics

Parnax Lab Limited's stock has gained approximately 38.60399% over the past 52 weeks. The 50-day moving average sits at 145.04, while the 200-day moving average is 131.72.

Beta (5Y)N/A
52-Week Price Change38.60399%
50-Day Moving Average145.04
200-Day Moving Average131.72
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Parnax Lab Limited generated 2.49B in revenue and converted that into 117.89M in net income, yielding earnings per share of 10.28. EBITDA reached 192.04M, while operating income came in at 192.04M.

Revenue2.49B
Gross Profit1.01B
Operating Income192.04M
Pretax Income159.07M
Net Income117.89M
EBITDA192.04M
EBIT192.04M
Earnings Per Share (EPS)10.28

Balance Sheet

Parnax Lab Limited holds 22.63M in cash and equivalents against 827.84M in total debt, resulting in a net debt position of 741.88M. Total book value stands at 114.86M, with working capital of -28.04M providing operational flexibility.

Cash & Cash Equivalents22.63M
Total Debt827.84M
Net Debt741.88M
Equity (Book Value)114.86M
Book Value Per Share10.01
Working Capital-28.04M

Margins

Parnax Lab Limited operates with a gross margin of 40.82, reflecting its pricing power and cost economics. The operating margin of 7.73 and net profit margin of 4.74 provide insight into operational efficiency.

Gross Margin40.82
Operating Margin7.73
Pretax Margin6.40
Profit Margin4.74
EBITDA Margin7.73

Scores

Parnax Lab Limited posts an Altman Z-Score of 2.03, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.03